U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

METIAMIDE

MORE DETAILS

  3K7670861M

Status:
Investigational
Source:
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1978;30(4):299-304.: Not Applicable Human clinical trial Completed Gastrointestinal Diseases
Source URL:
https://pubmed.ncbi.nlm.nih.gov/30144
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
4-trimethylaminobutyraldehyde dehydrogenase
1
Benzodiazepine receptors; peripheral & central
9
Histamine H2 receptor
46
Conditions:
Duodenal ulcer
49
Metiamide is an antagonist of histamine H2-receptors synthesized at Smith Kline & French Laboratories. It potently inhibited gastric acid secretion. Metiamide demonstrated promising clinical effects in patients with duodenal ulcers but questionable safety.

Methylamine

MORE DETAILS

BSF23SJ79E

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

Methylammonium bromide

MORE DETAILS

NDV5PY4944

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

METHYLAMINE HYDROCHLORIDE

MORE DETAILS

M439EX322K

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966